Cryo-Cell reports Q3 EPS 13c vs. 8c last year

Reports Q3 revenue $8.07M vs. $7.87M last year. David Portnoy, Chairman of the Board and Co-CEO, commented, “As previously reported, the Company is exploring strategic alternatives to maximize shareholder value and that process remains underway. There can be no assurance that a transaction will be consummated. Also, please note that significant disclosures are available in the Company’s Form 10-Q, filed with the SEC on October 15, associated with the filing of the Company’s Demand for Arbitration with Duke University. Consequently, the Company’s proposed spinoff of Celle is currently on hold.”